G. Francis

4.2k total citations
36 papers, 2.3k citations indexed

About

G. Francis is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, G. Francis has authored 36 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 7 papers in Rheumatology and 6 papers in Neurology. Recurrent topics in G. Francis's work include Multiple Sclerosis Research Studies (26 papers), Peripheral Neuropathies and Disorders (5 papers) and Ultrasound and Hyperthermia Applications (5 papers). G. Francis is often cited by papers focused on Multiple Sclerosis Research Studies (26 papers), Peripheral Neuropathies and Disorders (5 papers) and Ultrasound and Hyperthermia Applications (5 papers). G. Francis collaborates with scholars based in Canada, United States and United Kingdom. G. Francis's co-authors include Jack P. Antel, Douglas L. Arnold, Paul M. Matthews, Sridar Narayanan, Nicola De Stefano, D. Louis Collins, Frederik Barkhof, D. W. Paty, D. H. Miller and Stephen C. Reingold and has published in prestigious journals such as Blood, Brain and Neurology.

In The Last Decade

G. Francis

36 papers receiving 2.2k citations

Peers

G. Francis

PFM

NEURO

RNMI

RHEUM

Sean Morrissey Germany

P. Perini Italy

Cristina Auger Spain

A. Campi Italy

Francesca Bagnato United States

Darin T. Okuda United States

Andreas Bitsch Germany

Ángela Vidal‐Jordana Spain

Daniel Pelletier United States

Marcelo Kremenchutzky Canada

Sean Morrissey Germany

G. Francis

1.5k ×0.9

PFM

759 ×1.1

NEURO

556 ×1.1

RNMI

479 ×1.2

RHEUM

265 ×0.8

Citations per year, relative to G. Francis G. Francis (= 1×) peers Sean Morrissey

Countries citing papers authored by G. Francis

Since Specialization

Citations

This map shows the geographic impact of G. Francis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Francis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Francis more than expected).

Fields of papers citing papers by G. Francis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Francis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Francis. The network helps show where G. Francis may publish in the future.

Co-authorship network of co-authors of G. Francis

This figure shows the co-authorship network connecting the top 25 collaborators of G. Francis. A scholar is included among the top collaborators of G. Francis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Francis. G. Francis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Allen, C., G. Francis, James Martín, & Malcolm Boyce. (2017). Regulatory experience of TOPS: an internet-based system to prevent healthy subjects from over-volunteering for UK clinical trials. European Journal of Clinical Pharmacology. 73(12). 1551–1555. 5 indexed citations

Michael, Benedict, J.G. Cunniffe, Alastair Miller, et al.. (2010). Effect of delayed lumbar punctures on the diagnosis of acute bacterial meningitis in adults. Emergency Medicine Journal. 27(6). 433–438. 77 indexed citations

Graber, Jerome, Min Zhan, David A. Ford, et al.. (2005). Interferon-β-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis. Journal of Neuroimmunology. 161(1-2). 169–176. 32 indexed citations

Oger, Joël, G. Francis, & Peter Chang. (2005). Prospective assessment of changing from placebo to IFN beta-1a in relapsing MS: The PRISMS study. Journal of the Neurological Sciences. 237(1-2). 45–52. 16 indexed citations

Sandberg‐Wollheim, Magnhild, C. T. Bever, Barrie J. Hurwitz, et al.. (2005). Comparative tolerance of IFN beta-1a regimens in patients with relapsing multiple sclerosis. Journal of Neurology. 252(1). 8–13. 25 indexed citations

Freedman, Mark S., G. Francis, E. A. C. M. Sanders, et al.. (2005). Randomized study of once-weekly interferon β-1a therapy in relapsing multiple sclerosis: three-year data from the OWIMS study. Multiple Sclerosis Journal. 11(1). 41–45. 34 indexed citations

Shi, Yu, et al.. (2002). A New Cell Line-Based Neutralization Assay for Primary HIV Type 1 Isolates. AIDS Research and Human Retroviruses. 18(13). 957–967. 29 indexed citations

Pike, G. Bruce, Nicola De Stefano, Sridar Narayanan, et al.. (2000). Multiple Sclerosis: Magnetization Transfer MR Imaging of White Matter before Lesion Appearance on T2-weighted Images. Radiology. 215(3). 824–830. 149 indexed citations

Rice, G, et al.. (1999). Treatment with Interferon Beta-1b Improves Quality of Life in Multiple Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 26(4). 276–282. 57 indexed citations

10.

Noseworthy, John H., Peter C. O’Brien, Brandon J. Erickson, et al.. (1998). The Mayo Clinic-Canadian cooperative trial of sulfasalazine in active multiple sclerosis. Neurology. 51(5). 1342–1352. 74 indexed citations

11.

Matthews, Paul M., Nicola De Stefano, Sridar Narayanan, et al.. (1998). Putting Magnetic Resonance Spectroscopy Studies in Context: Axonal Damage and Disability in Multiple Sclerosis. Seminars in Neurology. 18(3). 327–336. 135 indexed citations

12.

Nance, Patricia W., W. A. Sheremata, Sharon Lynch, et al.. (1997). Relationship of the Antispasticity Effect of Tizanidine to Plasma Concentration in Patients With Multiple Sclerosis. Archives of Neurology. 54(6). 731–736. 61 indexed citations

13.

Narayanan, Sridar, Lili Fu, Erik P. Pioro, et al.. (1997). Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions. Annals of Neurology. 41(3). 385–391. 187 indexed citations

14.

Stefano, Nicola De, Paul M. Matthews, Sridar Narayanan, et al.. (1997). Axonal dysfunction and disability in a relapse of multiple sclerosis: Longitudinal study of a patient. Neurology. 49(4). 1138–1141. 62 indexed citations

15.

Kamber, Micheline, et al.. (1995). Model-based 3-D segmentation of multiple sclerosis lesions in magnetic resonance brain images. IEEE Transactions on Medical Imaging. 14(3). 442–453. 156 indexed citations

16.

Haegert, David G., et al.. (1990). Multiple sclerosis and HLA class II susceptibility and resistance genes. Journal of Neuroscience Research. 26(1). 66–73. 19 indexed citations

17.

Haegert, David G., et al.. (1990). Multiple Sclerosis in French Canadians: Evidence for HLA Class II Susceptibility and Resistance Genes. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 17(4). 382–386. 7 indexed citations

18.

Antel, Jack P., et al.. (1989). Activated suppressor cell function in severely disabled patients with multiple sclerosis. Annals of Neurology. 25(2). 204–207. 18 indexed citations

19.

Haegert, David G., et al.. (1989). HLA‐DRβ, ‐DQα, and ‐DQβ restriction fragment length polymorphisms in multiple sclerosis. Journal of Neuroscience Research. 23(1). 46–54. 17 indexed citations

20.

Lapierre, Yves, et al.. (1987). Treatment of Spasticity with Tizanidine in Multiple Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 14(S3). 513–517. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact